These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9990464)

  • 1. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.
    Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jan; 9(1):97-102. PubMed ID: 9990464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.
    Huang Y; Kegeles LS; Bae S; Hwang D; Roth BL; Savage JE; Laruelle M
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1375-7. PubMed ID: 11378358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).
    Löber S; Hübner H; Utz W; Gmeiner P
    J Med Chem; 2001 Aug; 44(17):2691-4. PubMed ID: 11495580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.
    Kulagowski JJ; Broughton HB; Curtis NR; Mawer IM; Ridgill MP; Baker R; Emms F; Freedman SB; Marwood R; Patel S; Patel S; Ragan CI; Leeson PD
    J Med Chem; 1996 May; 39(10):1941-2. PubMed ID: 8642550
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine.
    Lanig H; Utz W; Gmeiner P
    J Med Chem; 2001 Apr; 44(8):1151-7. PubMed ID: 11312915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range.
    Abdel-Fattah MA; Lehmann J; Abadi AH
    Chem Biodivers; 2013 Dec; 10(12):2247-66. PubMed ID: 24327445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Di- and trisubstituted pyrazolo[1,5-a]pyridine derivatives: synthesis, dopamine receptor binding and ligand efficacy.
    Löber S; Aboul-Fadl T; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2002 Feb; 12(4):633-6. PubMed ID: 11844688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands.
    Curtis NR; Kulagowski JJ; Leeson PD; Ridgill MP; Emms F; Freedman SB; Patel S; Patel S
    Bioorg Med Chem Lett; 1999 Feb; 9(4):585-8. PubMed ID: 10098669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626.
    Vangveravong S; Taylor M; Xu J; Cui J; Calvin W; Babic S; Luedtke RR; Mach RH
    Bioorg Med Chem; 2010 Jul; 18(14):5291-300. PubMed ID: 20542439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively.
    Pillai G; Brown NA; McAllister G; Milligan G; Seabrook GR
    Neuropharmacology; 1998 Aug; 37(8):983-7. PubMed ID: 9833627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.
    Sanner MA; Chappie TA; Dunaiskis AR; Fliri AF; Desai KA; Zorn SH; Jackson ER; Johnson CG; Morrone JM; Seymour PA; Majchrzak MJ; Faraci WS; Collins JL; Duignan DB; Prete Di CC; Lee JS; Trozzi A
    Bioorg Med Chem Lett; 1998 Apr; 8(7):725-30. PubMed ID: 9871530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina.
    Patel S; Chapman KL; Marston D; Hutson PH; Ragan CI
    Neuropharmacology; 2003 Jun; 44(8):1038-46. PubMed ID: 12763097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
    Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI
    J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands.
    Haubmann C; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3143-6. PubMed ID: 10560741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Disubstituted pyrroles: synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356.
    Bergauer M; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1937-40. PubMed ID: 12113813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
    Bristow LJ; Kramer MS; Kulagowski J; Patel S; Ragan CI; Seabrook GR
    Trends Pharmacol Sci; 1997 Jun; 18(6):186-8. PubMed ID: 9226994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.